Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Hayden

Showing results (41-50 of 172) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|March 11, 2000
Influenza virus neuraminidase inhibitorsL V Gubareva, L Kaiser, F G Hayden
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 30, 1999
Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infectionL Kaiser, M S Briones, F G Hayden
The Journal of Infectious Diseases|April 16, 1998
Emergence of drug resistance during an influenza epidemic: insights from a mathematical modelN I Stilianakis, A S Perelson, F G Hayden
The Pediatric Infectious Disease Journal|March 1, 1988
Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptomsM J Gaffey, D L Kaiser, F G Hayden
The Journal of Infectious Diseases|May 1, 1980
Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virusF G Hayden, W J Hall, R G Douglas
JAMA|February 11, 1983
Severe metabolic complications in a cross-country runner with sickle cell traitK J Helzlsouer, F G Hayden, A D Rogol
JAMA|July 9, 1982
Necrotizing balanitis due to herpes simplex type 1R D Powers, M F Rein, F G Hayden
The Journal of Infectious Diseases|November 1, 1983
Human tolerance and histopathologic effects of long-term administration of intranasal interferon-alpha 2F G Hayden, S E Mills, M E Johns
Antimicrobial Agents and Chemotherapy|February 1, 1988
Intranasal recombinant alfa-2b interferon treatment of naturally occurring common coldsF G Hayden, D L Kaiser, J K Albrecht
Antiviral Research|March 1, 1992
Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccineS J Sperber, B V Smith, F G Hayden
Pageof 18

Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|March 11, 2000
Influenza virus neuraminidase inhibitorsL V Gubareva, L Kaiser, F G Hayden
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 30, 1999
Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infectionL Kaiser, M S Briones, F G Hayden
The Journal of Infectious Diseases|April 16, 1998
Emergence of drug resistance during an influenza epidemic: insights from a mathematical modelN I Stilianakis, A S Perelson, F G Hayden
The Pediatric Infectious Disease Journal|March 1, 1988
Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptomsM J Gaffey, D L Kaiser, F G Hayden
The Journal of Infectious Diseases|May 1, 1980
Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virusF G Hayden, W J Hall, R G Douglas
JAMA|February 11, 1983
Severe metabolic complications in a cross-country runner with sickle cell traitK J Helzlsouer, F G Hayden, A D Rogol
JAMA|July 9, 1982
Necrotizing balanitis due to herpes simplex type 1R D Powers, M F Rein, F G Hayden
The Journal of Infectious Diseases|November 1, 1983
Human tolerance and histopathologic effects of long-term administration of intranasal interferon-alpha 2F G Hayden, S E Mills, M E Johns
Antimicrobial Agents and Chemotherapy|February 1, 1988
Intranasal recombinant alfa-2b interferon treatment of naturally occurring common coldsF G Hayden, D L Kaiser, J K Albrecht
Antiviral Research|March 1, 1992
Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccineS J Sperber, B V Smith, F G Hayden
Pageof 18